Episode Details

FDA just approved updated COVID-19 vaccines from Pfizer-BioNTech and Moderna, specifically targeting the XFG subvariant expected to dominate next winter. Pfizer’s Comirnaty is for those 65+ and high-risk individuals aged 5–64. Moderna’s Spikevax covers ages 6 months–64 with high-risk conditions plus everyone 65+, while mNEXSPIKE targets adults 65+ and high-risk teens/adults 12–64. These updates ensure better match against current virus strains — shots are already shipping and should be available at pharmacies and clinics soon.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/efe0867e1958f025